Limited sampling strategies for sirolimus after pediatric renal transplantation

Pediatric Transplantation

Volumn 13, Issue 8, 2009, Pages 1020-1026

  Forbes, Nauzer ^b   Schachter, Asher D ^a   Yasin, Abeer ^b   Sharma, Ajay P ^b   Filler, Guido ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Area under the curve; Once daily dosing; Pharmacokinetic monitoring; Sirolimus; Twice daily dosing

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SAMPLING; SCHOOL CHILD; STATISTICAL SIGNIFICANCE;

AREA UNDER CURVE; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LINEAR MODELS; RETROSPECTIVE STUDIES; SIROLIMUS;

EID: 73349116560     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01110.x     Document Type: Article

References (14)

1. Morales JM, Wramner L, Kreis H. Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients. Am J Transplant 2002 : 2 : 436 442.
2. Schachter AD, Meyers KE, Spaneas LD, et al. Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol. Pediatr Transplant 2004 : 8 : 171 177.
3. Filler G, Bendrick-Peart J, Strom T, Zhang YL, Johnson G, Christians U. Characterization of sirolimus metabolites in pediatric solid organ transplant recipients. Pediatr Transplant 2008, doi :.
4. Filler G, Womiloju T, Feber J, Lepage N, Christians U. Effect of adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients. Am J Transplant 2005 : 5 : 2001 2005.
5. Schachter AD, Benfield MR, Wyatt RJ, et al. Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy. Pediatr Transplant 2006 : 10 : 914 919.
6. Filler G, Mai I, Filler S, Ehrich JH. Abbreviated cyclosporine AUCs on Neoral - the search continues. Pediatr Nephrol 1999 : 13 : 98 102.
7. Filler G, Mai I. Limited sampling strategy for mycophenolic acid area under the curve. Ther Drug Monit 2000 : 22 : 169 173.
8. Filler G, Feber J, Lepage N, Weiler G, Mai I. Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children. Pediatr Transplant 2002 : 6 : 411 418. (Pubitemid 35265193)
9. Sindhi R, Webber S, Venkataramanan R, et al. Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. Transplantation 2001 : 72 : 851 855.
10. Sindhi R, Webber S, Goyal R, Reyes J, Venkataramanan R, Shaw L. Pharmacodynamics of sirolimus in transplanted children receiving tacrolimus. Transplant Proc 2002 : 34 : 1960.
11. Schubert M, Venkataramanan R, Holt DW, et al. Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients. Am J Transplant 2004 : 4 : 767 773.
12. Tejani A, Alexander S, Ettenger R, et al. Safety and pharmacokinetics of ascending single doses of sirolimus (Rapamune, rapamycin) in pediatric patients with stable chronic renal failure undergoing dialysis. Pediatr Transplant 2004 : 8 : 151 160.
13. Bland M, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 : 1 : 307 310.
14. Merkel S, Mogilevskaja N, Mengel M, Haller H, Schwarz A. Side effects of sirolimus. Transplant Proc 2006 : 38 : 714 715.